Vimarsana
Biggest News Aggregation in the World

Target Pharmasolutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Target Pharmasolutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Target Pharmasolutions Today - Breaking & Trending Today

Target RWE Creates 35 New Disease Registries | North Carolina Biotechnology Center - Vimarsana News

Target RWE Creates 35 New Disease Registries | North Carolina Biotechnology Center

Target RWE, a Durham-based clinical analytics company, has launched 35 new observational disease-state registries to support decision-making in health care.

Registry trials can provide revenue 'backbone' for gastroenterology practice - Vimarsana News

Registry trials can provide revenue 'backbone' for gastroenterology practice

MIAMI — Incorporating clinical trials into daily practice can both enhance patient treatment options and provide a stream of reimbursement revenue to support the practice, according to a presenter at the Scrubs and Heels Summit. “In my practice, I always ask myself, no matter where a patient is in the course of disease: Would this patient potentially benefit from inclusion in a

Source: healio.com
Target RWE Acquires NoviSci, Gains Amgen Investment | North Carolina Biotechnology Center - Vimarsana News

Target RWE Acquires NoviSci, Gains Amgen Investment | North Carolina Biotechnology Center

Target RWE Acquires NoviSci, Gains Amgen Investment Target RWE, a clinical data company based in Durham, didn’t have to go far to find a strategic partner to boost its analytical prowess. The company has acquired NoviSci, a software analysis and services company located in downtown Durham, seven miles away, while also scoring an investment in the newly combined company from California biotech pioneer Amgen. “With the addition of NoviSci’s novel analytics platform and experienced team, Target provides a highly adaptive environment to accelerate insights and reproducible research output f...